Delivery Order SPE2DB20D1100-SPE2DB24FA5P5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4564247365 - Bupropion HCL XL 150 mg Tablets in 500 count bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price Delivery Order has a ceiling value of $54,382.63 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Bupropion HCL XL 150 mg tablets in 500-count size, with a ceiling value of $10,602.74 and a period of performance through March 22, 2024. The contract is a firm fixed price delivery order, with no set-aside designation used....
- This federal contract award is for the delivery of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA). The $39,018.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 29, 2024. The contract has an ultimate completion date of April 1, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,564,460 units of Bupropion HCL XL 150 mg tablets. The $59,427.55 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $86,361.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 24, 2024. The contract covers the delivery of 4563416633 - BUPROPION HCL XL 150 MG TABLET 500S, a generic pharmaceutical product, to support military and government healthcare...
- This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,596.22, is for the delivery of bupropion HCL XL 300 mg tablets. The contract is a firm fixed-price delivery order that runs through January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZYJ, is for the delivery of 4,563,586,968 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order with a ceiling value of $23,937.54. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA5P5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,368.94 firm fixed-price delivery order covers the supply of 4563862693 bupropion HCL XL 150 mg tablets to support military healthcare programs. The contract has a period of performance through March 6, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 3/5/24 |